ROS1 and inflammatory myofibroblastic tumor: Although the histology is similar, in IMT, frequently ALK, ROS1 or pan-Trk expression can be demonstrated by immunohistochemistry as indicator of an underlying ALK, ROS1 or NTRK gene rearrangement [18].